AI in Life Sciences Market Size, Overview, Growth, Demand and Forecast to 2031

1. Global AI in Life Sciences Market Surges to a Staggering USD 25.2 Billion in 2022, CAGR Forecast Growth from 2024 to 2031 The Global AI in Life Sciences Market is poised to reach an estimated worth of USD 25.2 Billion in 2022, with a projected growth rate of 9.4% between 2023 to 2032, according to a comprehensive study released today. This transformative intersection of artificial intelligence (AI) and life sciences is revolutionizing research, drug discovery, patient care, and operational efficiencies within the healthcare and pharmaceutical sectors. The report delves into the market’s intricacies, segmenting it by type, component, delivery model, application, end user, and region/country. The United States and Canada lead the charge in AI adoption, boasting robust healthcare systems and substantial investments in AI-driven technologies for drug discovery, genomics, personalized medicine, and clinical research. Western European countries, including the UK, Germany, and France, are not far behind, exhibiting strong AI adoption in life science analytics, focusing on drug development, healthcare dataanalysis, genomics research, and improving patient outcomes.

2. Request PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @https://sanglobalresearch.com/request-sample/3133 Countries in Asia, such as China, Japan, South Korea, and India, are significantly investing in AI for life science analytics, exploring applications in genomics, drug discovery, and precision medicine. Latin America, Africa, and the Middle East, though experiencing varying levels of AI adoption, are making strides in utilizing AI for healthcare data analysis and research. The drivers behind this growth are rooted in technological advancements in AI, particularly in machine learning algorithms and natural language processing. The increasing volume and diversity of healthcare data necessitate advanced analytics tools powered by AI, fostering collaboration between research institutions, pharmaceutical companies, and technology firms. Get Customization on AI in Life Sciences Market: https://www.sanglobalresearch.com/customization/3133 Key Companies Profiled:Oracle, IBM, SAS, Accenture, IQVIA, Cognizant, Wipro, Optum, Microsoft, MaxisIT Inc., Cotiviti, Amazon Web Services (AWS) Global AI in Life Sciences Market Segmentation: The Global AI in Life Science Analytics Market is segmented by type, by component, by delivery model, by application, by end user and region/country. By Type: Based on the type, the Global AI in Life Science Analytics Market is bifurcated into Descriptive, Predictive & Prescriptive Analytics — where Descriptive Analytics is dominating and ahead in terms of share.The integration of artificial intelligence (AI) in life science analytics has significantly transformed the landscape of descriptive analytics within the global market. Descriptive analytics, a fundamental aspect of AI-driven analytics, involves the analysis of historical data to understand past trends, patterns, and events within life sciences. This facet of AI applications enables pharmaceutical companies, healthcare providers, and researchers to extract valuable insights from massive volumes of data generated in the field of life sciences. By utilizing descriptive analytics powered by AI, stakeholders can gain a comprehensive understanding of patient demographics, disease patterns, treatment efficacy, and healthcare operational processes. 

3. By Component: Based on the Component, the Global AI in Life Science Analytics Market is bifurcated into Services & Software — where Services is dominating and ahead of Software in terms of share.  By Delivery Model: Based on the Delivery Model, the Global AI in Life Science Analytics Market is bifurcated into On Premise & on Demand — where the On Premise is dominating and ahead in terms of share.  By Application: Based on the Application, the Global AI in Life Science Analytics Market is bifurcated into R & D, Preclinical Trials, Clinical Trials, Sales & Mktg, Regulatory Compliance, Supply Chain Optimization & Pharmacovigilance — where the R & D is dominating and ahead of others in terms of share.  By End User: Based on the End User, the Global AI in Life Science Analytics Market is bifurcated into Pharma & Bio Tech, Medical Devices, and Research Centers & Third Party Administrator — where the Pharma & Bio Tech Companies are dominating and ahead of others in terms of share.  On the basis of region North America Europe Asia Pacific South America and Middle East and Africa      Our Latest Reports: Digital Twin Market: https://www.sanglobalresearch.com/report/digital-twin- market/3150 Wound Care Market: https://www.sanglobalresearch.com/report/wound-care- market/3154 Hand Held X-Rays Market: https://www.sanglobalresearch.com/report/hand-held-x- rays-market/3155

4. About About Us: At San Global Research Report, we pride ourselves on our commitment to quality and accuracy. Our team of experienced researchers utilizes a combination of quantitative and qualitative methods to ensure that our findings are both accurate and reliable. With a strong emphasis on responsiveness, transparency, and collaboration, we work closely with our clients to understand their objectives and deliver actionable insights. Learn more about our research approach and how it can benefit your business. Us: Contact Contact Us: Phone: +91 9209275355 Us: Email Id: hello@sanglobalresearch.com